[Locally applied cardioselective beta blocker and histamine provocation in patients with obstructive airway disease].
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D015784:Betaxolol; D001985:Bronchial Provocation Tests; D005541:Forced Expiratory Volume; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006632:Histamine; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000503:physiopathology*; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000008:administration & dosage / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011412:Propanolamines; D006632:Histamine; D015784:Betaxolol
Lokal applizierte kardioselektive Betablocker und Histaminprovokation bei Patienten mit obstruktiven Atemwegerkrankungen.